SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Morgan Stanley Initiates Coverage On AlloVir with Overweight Rating, Announces Price Target of $49

Morgan Stanley analyst Matthew Harrison initiates coverage on AlloVir (NASDAQ:ALVR) with a Overweight rating and announces Price Target of $49.

Benzinga · 08/24/2020 11:36
Morgan Stanley analyst Matthew Harrison initiates coverage on AlloVir (NASDAQ: ALVR) with a Overweight rating and announces Price Target of $49.